Abstract
Cardiovascular Diseases (CVD) stand as a major cause of mortality, particularly affecting individuals aged 45-64 (middle-aged) and those aged 65 and above (elderly). The economic burden of CVD is substantial, surpassing $351.2 billion, with expenses doubling over two decades. While projections for 2035 indicate stable costs for young adults, expenses for middle-aged and elderly individual…